Antihypertensive drug

Olmesartan medoxomil 10 mg

Case reports indicate that symptoms appear months to years after olmesartan initiation.

Olmesartan 40 mg

Despite being the seventh ARB approved by the Food and Drug Administration and despite a lack of hard outcome trial data supporting its use, olmesartan is widely prescribed, with estimated worldwide sales of 2 billion US dollars in 2009.

Olmesartan 20 mg

Patients with renal insufficiency have elevated serum concentrations of olmesartan compared to subjects with normal renal function.

Olmesartan medoxomil 40 mg

Severe, chronic diarrhea with considerable weight loss may develop months to years after starting olmesartan.

Olmesartan 10 mg

For those who cannot afford the cost of olmesartan, certain patient assistance programs are available.

Olmesartan medoxomil 20 mg

Concurrent administration of bile acid sequestering agent colesevelam hydrochloride reduces the systemic exposure and peak plasma concentration of olmesartan.


© Copyright 2019-2020 | All rights reserved. Site Map